The Neurogenetics Lab (Houlden Group)

We focus on neurodegeneration, peripheral nerve disease, ataxias, and movement disorders, using a combination of genetic, functional cell biology, and neuropathological methods. As genetic technology rapidly advances, our research emphasizes analyzing RNA, protein expression, and interactions in human tissues, which is crucial for developing future treatments. Our goal is to translate these findings into improved patient outcomes and disease-modifying treatments.

Partners and Funders

We sincerely appreciate the essential support from patients and families, our UK and international collaborators, brainbanks, and biobanks. We also acknowledge the significant funding provided by The Wellcome Trust, The MRC, The MSA Trust, The National Institute for Health Research (NIHR), University College London Hospitals Biomedical Research Centre, The Michael J. Fox Foundation (MJFF), The Fidelity Trust, Rosetrees Trust, Alzheimer’s Research UK (ARUK), MSA Coalition, NIH NeuroBioBank, and the MRC Brainbank Network. 

 Donate

   Links

Publications 

https://profiles.ucl.ac.uk/10164-henry-houlden

• Rare Disease Day
• Feature: Why rare diseases are key for scientific discovery
• Neurogenetics Lab